RBC Capital analyst Ben Hendrix maintained a Hold rating on SelectQuote (SLQT – Research Report) on May 5 and set a price target of $3.00. The company’s shares closed last Friday at $2.58, close to its 52-week low of $1.93.
According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -5.5% and a 22.2% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.
Currently, the analyst consensus on SelectQuote is a Hold with an average price target of $3.46, which is a 34.1% upside from current levels. In a report issued on May 5, Piper Sandler also maintained a Hold rating on the stock with a $3.00 price target.
Based on SelectQuote’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $195 million and GAAP net loss of $137 million. In comparison, last year the company earned revenue of $358 million and had a net profit of $89.86 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of commission. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQoute Auto & Home.
Read More on SLQT:
- Canfor (CFPZF) Receives a Buy from RBC Capital
- Karyopharm Therapeutics (KPTI) Gets a Hold Rating from RBC Capital
- RBC Capital Sticks to Their Buy Rating for Clearwater Analytics Holdings (CWAN)
- Karuna Therapeutics (KRTX) Receives a Buy from RBC Capital
- Sotera Health (SHC) Gets a Buy Rating from RBC Capital